Illinois Cancer Specialists

Industry News

FDA Approves Two Dako Assays As Companion Diagnostics For Genentech's New Breast Cancer Medicine Kadcyla

Mar 07, 2013

Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Drug Administration for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays... Read More

To Improve Patient Care, Better Estrogen Testing Methods Needed

Mar 07, 2013

In a Position Statement, The Endocrine Society advocates that all methods for measuring estrogens, which play a crucial role in human biology, be made traceable to a common standard... Read More

Study: Barriers To Prostate Cancer Care: Affordable Care Is Not Enough

Mar 07, 2013

A combination of financial, cultural and communication barriers plays a role in preventing underserved Latino men with prostate cancer from accessing the care and treatment they need, according to a new study by researchers at the UCLA School of Nursing... Read More

Inhibiting Protein Prevents Metastasis To Lungs In Mouse Model Of Melanoma

Mar 07, 2013

Researchers have identified a critical protein role in the metastasis of melanoma, the most serious form of skin cancer... Read More

Study Supports Current Screening Practices And Recommendations For Colonoscopy

Mar 07, 2013

A new study led by a researcher at the Perelman School of Medicine at the University of Pennsylvania adds support to current medical recommendations stating that screening colonoscopy substantially reduces an average-risk adult's likelihood of being diagnosed with advanced colorectal cancer (CRC) in either the right or left side of the colon... Read More

First Successful Blocking Of Tumor Development In A Genetic Mouse Model Of An Incurable Human Cancer

Mar 07, 2013

"To my knowledge, this is the first time that a mouse model of a genetically defined malignant human cancer has been generated in which the formation of the tumor from beginning to end can be monitored and in which blocking the pathway cures the mouse of the tumor," said Dr... Read More

Imroved Understanding Of Peripheral Neuropathy

Mar 07, 2013

One in 25,000 people worldwide is affected by neurofibromatosis type 2 (NF2), a condition where the loss of a tumour suppressor called Merlin results in multiple tumours in the brain and nervous system. Sufferers may experience 20 to 30 tumours at any one time and such numbers often lead to hearing loss, disability and eventually death... Read More